- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Myeloma in United Kingdom
Total 6636 results
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedLymphoma | Multiple Myeloma | Acute Myelogenous LeukemiaUnited States
-
Altor BioScienceNational Cancer Institute (NCI)TerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Washington University School of MedicineGenzyme, a Sanofi CompanyCompletedRelapsed Or Refractory Multiple MyelomaUnited States
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCWithdrawnMultiple Myeloma, RefractoryUnited States
-
Precision BioSciences, Inc.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
Cougar Biotechnology, Inc.TerminatedRefractory Multiple MyelomaUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruiting
-
Kite, A Gilead CompanyArcellx, Inc.RecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterConquer Cancer FoundationCompletedGeriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple MyelomaMultiple Myeloma | Myeloma | Disability Physical | Disabilities MultipleUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Kiadis PharmaTerminatedLymphoma | Myeloid Leukemia | Myeloproliferative Disorders | Multiple Myeloma | Myelodysplastic Syndrome | Lymphoblastic LeukemiaCanada, Netherlands, Germany, Belgium, United States, Italy, United Kingdom
-
NHS Greater Glasgow and ClydeBiogenEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | ISS Stage III Plasma Cell Myeloma | ISS Stage II Plasma Cell Myeloma | ISS Stage I Plasma Cell MyelomaUnited States
-
North Bristol NHS TrustUniversity of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaboratorsUnknownProgressive Multiple SclerosisUnited Kingdom
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedProgressive Multiple SclerosisUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Actinium PharmaceuticalsTerminatedRefractory Multiple MyelomaUnited States
-
Anaveon AGRecruitingLung Cancer | Advanced Solid Tumor | Adult DiseaseUnited Kingdom, Switzerland, Spain
-
University of MiamiKaryopharm Therapeutics IncRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
Immunovative Therapies, Ltd.TerminatedAdvanced or Refractory Leukemia, Lymphoma, Multiple MyelomaUnited States
-
Sorrento Therapeutics, Inc.CompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Glasgow Caledonian UniversityUnknown
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMyelodysplastic Syndromes | Myeloid Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Plasma Cell Myeloma | Lymphoid LeukemiaUnited States
-
Queen Mary University of LondonMerck Sharp & Dohme LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States, Singapore
-
National Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Unspecified Adult Solid Tumor, Protocol Specific | Refractory Multiple Myeloma | Refractory Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia, Bosnia and Herzegovina
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford HospitalCompleted
-
Barts & The London NHS TrustCompletedEmergencies | Trauma Injury | Trauma, MultipleUnited Kingdom
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingMultiple Myeloma | Newly Diagnosed Multiple Myeloma | Autologous Stem Cell TransplantationUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Netherlands, Italy
-
Janssen-Cilag International NVCompletedMultiple MyelomaTurkey, Greece, Czech Republic, Austria, Germany, Sweden, United Kingdom, Denmark
-
University Hospitals of North Midlands NHS TrustCompletedMultiple MyelomaUnited Kingdom
-
Washington University School of MedicineCompletedRelapsed, Refractory or Plateau Phase Multiple MyelomaUnited States
-
Celgene CorporationCompletedNewly Diagnosed Multiple MyelomaSpain, Netherlands, Austria, Australia, Italy, Russian Federation, United Kingdom, Israel, Belgium, Greece, Germany, Poland, Turkey, France, Denmark, Czech Republic, Belarus, Georgia, Ireland, Sweden, Switzerland, Ukraine
-
Mayo ClinicRecruitingPlasma Cell MyelomaUnited States